39 search results for: itch

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
Dermatology
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema

View more
Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
Dermatology
Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
expert video

Dr. Sarina Elmariah explains the importance of neuroimmune crosstalk in the development of prurigo nodularis.

View more
The Ripple Effect: Uncovering the Hidden Burden and Comorbidities of Prurigo Nodularis
Dermatology
The Ripple Effect: Uncovering the Hidden Burden and Comorbidities of Prurigo Nodularis
expert video

Dr. Sarina Elmariah explores the complex systemic burden of PN, from diverse clinical presentations and delayed diagnosis to the profound impact of itch, sleep disruption, comorbidities, and reduced quality of life.

View more
EADV 2025
Congress
17
September
2025
Congress
ADVENT at EADV 2025

Join leading dermatologists for educational symposia on atopic dermatitis, bullous pemphigoid, and chronic spontaneous urticaria at the EADV congress in Paris, France.

Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control
Dermatology
Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control
expert video

Join Drs. Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox as they share expert insights on the burden of pediatric CSU, as well as key considerations for disease diagnosis and treatment escalation in pediatric and adult patients.

View more
Prurigo Nodularis: Type 2 Inflammation Links Neuronal Dysfunction and Fibrosis
Dermatology
Prurigo Nodularis: Type 2 Inflammation Links Neuronal Dysfunction and Fibrosis
interactivity

This infographic highlights how PN is driven by type 2 inflammation, linking immune dysregulation, fibroblast activation, and neuronal dysfunction to nodule formation. It also shows how cytokine-mediated changes in neuronal architecture increase excitability and chronic itch, where resulting lesions and scarring significantly impact patients’ psychological well-being.

View more
ADVENT at EADV 2026
On Demand
Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control

Drs Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox shared expert perspectives on chronic spontaneous urticaria (CSU) during an engaging ADVENT symposium at EADV 2026 in Vienna, Austria. The symposium explored key considerations across the CSU patient journey, from diagnosis to disease control. Key topics included the multifaceted burden of CSU on patients, caregivers, and families, practical approaches to diagnosis and assessment of disease control, and considerations for treatment escalation and advanced therapy selection in adult and pediatric patients with CSU.

The Role of IL-4 and IL-13 in CSU Pathogenesis
Type 2 Inflammation
The Role of IL-4 and IL-13 in CSU Pathogenesis
interactivity

Dive into the complex pathophysiology of chronic spontaneous urticaria (CSU), where mast cell degranulation drives the hallmark signs and symptoms. This interactive infographic elucidates how key type 2 cytokines, specifically IL-4 and IL-13, contribute to mast cell activation, immune cell trafficking into the skin, and neuronal sensitization in CSU, which ultimately leads to the release of mediators like histamine that cause wheals, angioedema, and itch.

View more
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
Type 2 Inflammation
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

View more
Sarina Elmariah
Expert
Sarina Elmariah, MD, PhD, MPH

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

From Data to Decision: Unleashing Real-World Evidence for Smart Treatment Selection 
Dermatology
From Data to Decision: Unleashing Real-World Evidence for Smart Treatment Selection 
expert video

Dr. Pedro Bastos shares how real-world evidence for approved biologics is essential to inform the treatment of PN across diverse comorbid patient populations, including insights into rapid itch relief, progressive skin clearance, long-term outcomes, and safety.

View more